ClinChoice is seeking a Principal Biostatistician to join their biometrics team in Stirling, UK. This is a hybrid, full-time permanent position. The Principal Biostatistician will be responsible for protocol development and statistical analysis plans for assigned studies, providing statistical oversight and ensuring quality and consistency with project requirements.
Role Involves:
Protocol development including study design, sample size calculation, randomization, and statistical analysis plan.
Providing statistical oversight to studies.
Ensuring data accuracy and consistency for statistical analyses.
Developing statistical analysis plans.
Validating analysis and exploring alternative strategies.
Ensuring accuracy and consistency of statistical tables, figures, and data listings.
Writing statistical methods sections for reports.
Mentoring peers and providing training to less experienced statisticians.
Managing activities of statisticians across projects.
Requirements:
MS or PhD in Statistics, Biostatistics, or related field.
PhD with 3-5 years of experience or MS with 7-8 years of experience.
Strong oral and written communication skills.
Understanding of statistics, drug development process, and FDA regulations.
Pharmaceutical, CRO, or related industry experience with clinical trials.
What ClinChoice Offers:
Opportunity to work directly for a single sponsor while having the security of a global CRO.
Professional development and a supportive culture.
ClinChoice is a global provider of regulatory and scientific services, specializing in preparing and submitting compliant Material Safety Data Sheets (MSDS/SDS). The company supports multinational chemical manufacturing companies, offering hazard analysis, SDS authoring, and regulatory compliance expertise across US, EU, and other international markets. ClinChoice focuses on establishing structured processes for SDS preparation, and delivers comprehensive hazard assessments and SDS phrases based on global regulatory standards. They provide mentorship and review services.